GLAXOSMITHKLINE, LLC: $27.3M Department of Health and Human Services Contract
Summary
The Department of Health and Human Services awarded a $27.3M definitive contract to GLAXOSMITHKLINE, LLC for the supply of Relenza (zanamivir) Rotadisk, an influenza antiviral. The contract spans 2025-2028 and supports pandemic preparedness stockpiling. No publicly traded company is directly identified as the recipient, limiting direct market impact.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The $27.3M contract is small in scale and awarded to a private entity, so no direct public ticker impact.
- 2.Sector-level tailwinds for Healthcare, specifically antiviral stockpiling, remain intact but are not company-specific.
- 3.Investors should monitor broader HHS spending on medical countermeasures for potential future opportunities with public companies.
Market Implications
The contract has negligible immediate market implications given the private recipient and modest size. The broader Healthcare sector continues to see steady demand from government contracts, but this award alone does not alter the competitive landscape. Investors focused on pandemic preparedness should track larger awards to public firms such as GSK (parent of the LLC if matched) or competitors like Roche for Tamiflu.
⚡ Government Convergence
This signal is one of the converging government actions below.
Over the last 90 days, 35 separate government actions have converged on Biodefense / Pandemic Preparedness. What that means: federal dollars are already moving — agencies are soliciting bids and awarding contracts, not just talking, and legislation and executive action are building the policy and funding tailwind behind it. When independent channels move together like this — 26 federal contracts, 8 procurement notices and 1 bills — it's the clearest early tell that Washington is committing to biodefense / pandemic preparedness, the kind of build-up that reshapes the sector well before it's obvious in the headlines.
Converging government actions
- BillBeagle Brigade Act of 2023 · 2024-12-23
- BillNo Flight, No Fight Act of 2026 · 2026-02-05
- ContractGLOBAL HEALTH INVESTMENT CORPORATION: OTHER TRANSACTION AGREEMENT: BARDA VENTURES · 2026-04-30
- Procurement noticeSources Sought Notice - Pandemic Preparedness Plan Evaluation · 2026-05-13
- Procurement noticeRFI - Medical Countermeasures for the Treatment of Drug-Resistant Fungal Infections · 2026-05-21
- Procurement noticeRPP: BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-02
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-03
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-11
- ContractEMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.: ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) · 2026-06-26
- Procurement noticePresolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response · 2026-07-30
- ContractSIGA TECHNOLOGIES, INC.: PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF · 2026-08-07
- ContractGLAXOSMITHKLINE, LLC: $27.3M Department of Health and Human Services Contract · 2026-08-18
- ContractSTRING KING LACROSSE LLC: $95.9M Department of Health and Human Services Contract · 2026-08-19
- ContractSANOFI PASTEUR VAXDESIGN CORP: TAS::75 0140::TAS CLINICAL TRIAL IN A TEST TUBE FOR MEDICAL COUNTERMEASURE DEVELOPMENT · 2026-08-19
Full Analysis
This contract from HHS/ASPR for $27.3M over three years covers the procurement of Relenza (zanamivir), an inhaled antiviral used to treat influenza. The recipient, GLAXOSMITHKLINE, LLC, is a private entity not listed on public exchanges, so the award does not directly affect any specific ticker. However, the contract signals continued government investment in antiviral stockpiles and biodefense, which broadly supports the Healthcare sector, particularly companies involved in infectious disease treatments and pandemic preparedness. Related legislative signals include several maternal health bills, but none have a direct mechanism linking to this antiviral procurement. Supply chain effects are minimal without a publicly traded prime; however, generic manufacturers or raw material suppliers could indirectly benefit. Historically, similar HHS stockpile contracts provide stable but modest revenue streams for private firms, with no outsized market moves for the public sector.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
GENENTECH USA, INC: $37.5M Department of Health and Human Services Contract
GLAXOSMITHKLINE, LLC: $653M Department of Health and Human Services Contract Vehicle
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Contract Details
Recipient
GLAXOSMITHKLINE, LLC
Award Amount
$27,299,970
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DEFINITIVE CONTRACT
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →